Subject(s)
Adenine/analogs & derivatives , Anti-HIV Agents/administration & dosage , Benzoxazines/administration & dosage , Deoxycytidine/analogs & derivatives , Dideoxynucleosides/administration & dosage , HIV Infections/drug therapy , Lamivudine/administration & dosage , Organophosphonates/administration & dosage , Adenine/administration & dosage , Adenine/adverse effects , Alkynes , Anti-HIV Agents/adverse effects , Benzoxazines/adverse effects , CD4 Lymphocyte Count , Cardiovascular Diseases/chemically induced , Cyclopropanes , Deoxycytidine/administration & dosage , Deoxycytidine/adverse effects , Dideoxynucleosides/adverse effects , Drug Combinations , Emtricitabine , Female , Humans , Kidney Diseases/chemically induced , Lamivudine/adverse effects , Male , Middle Aged , Organophosphonates/adverse effects , Retrospective Studies , Tenofovir , Viral LoadABSTRACT
An assessment of the need to increase access to an outreach venue, the local sauna in Walsall, UK, frequented only by men who have sex with men, was undertaken. A case-notes review of the clients who attended the monthly outreach sessions at the sauna in the year 2007 was performed. Among the 287 men seen at the 12 outreach sessions, 37% had a sexually transmitted infection (STI). Of those tested positive, 88% had never had a previous STI. Twenty-one men had syphilis and a further six tested positive for HIV. Hepatitis B vaccination was completed for 41% of the clients seen. Those who tested positive for an STI said they would not have attended a conventional setting but accepted screening at the sauna. This confirmed the need to increase access at this outreach venue, and further funding has now been provided to have outreach sessions twice a month.
Subject(s)
Homosexuality, Male , Sexually Transmitted Diseases/etiology , Adult , Aged , Humans , Male , Middle Aged , Retrospective Studies , Risk , United Kingdom/epidemiologyABSTRACT
An assessment of risk-taking behaviour among men who have sex with men (MSM) attending a sauna venue was undertaken, using a standardized questionnaire, after which outreach screening was introduced targeting MSM. The epidemiology of the continuing outbreak of syphilis was reviewed to determine the factors driving the outbreak and assess the benefit of continuing outreach screening. Findings among the 163 respondents at the sauna included a high rate of casual sex and a tendency not to disclose HIV status. Over 12 months, 51 cases of early syphilis were recorded. Our review showed a decline in incidence in MSM after outreach screening, but an increase in heterosexual spread. Given the frequent anonymous nature of syphilis transmission, traditional contact tracing is ineffective. Outreach screening is required at gay venues and other community settings to target at-risk populations.
Subject(s)
Disease Outbreaks , Homosexuality, Male , Syphilis/epidemiology , Data Collection , Female , Humans , Male , Sex Work , Syphilis/prevention & control , Syphilis/transmission , United Kingdom/epidemiology , Unsafe SexABSTRACT
BACKGROUND: Nevirapine, a nonnucleoside analogue, has demonstrated suppression of human immunodeficiency virus (HIV) replication alone and in combination therapy. However, the durable suppression of HIV with nevirapine when used along with other nucleosides in HIV-infected patients who are treated in clinical practice needs further evaluation. PURPOSE: To evaluate the sustained efficacy of nevirapine in combination with two nucleoside analogues in the treatment of HIV-infected patients in routine clinical practice. DESIGN: A multicenter study from January 1997 to December 2000, with follow-up through 48 weeks, was conducted at four different genitourinary medicine clinics in the United Kingdom. Forty-four HIV-infected patients received nevirapine and two nucleoside analogues. Information from case notes regarding age, sex, side effects, viral load, and CD4 lymphocyte counts at baseline, 24 weeks, and 48 weeks was collected and analyzed. Virologic suppression, defined as HIV RNA concentration of less than 400 copies/mL at Weeks 24 and 48, was considered as the main outcome measure. RESULTS: Out of 44 patients, 41 were men with a mean age of 39.3 years (95% CI 36.7-41.8). The baseline viral load was 2.11 x 10(2) to 9.74 x 10(5) copies/mL (median 7.7 x 10(4) and CD4 counts 6 to 605 cells/dL (M = 247; 95% CI 198-295). Of 39 patients who completed 48 weeks of treatment, viral load suppression was attained in 31 patients (79.4%; 95% CI 66.8-92.0) at 24 weeks and in 27 patients (69.2%; 95% CI 54-83) at 48 weeks. The CD4 lymphocyte count increased in 32 (82%) patients (mean 106 cells/dL, 95% CI 73-139, p =.0001, Wilcoxon signed rank test) after 24 weeks and in 33 (84.6%) patients (mean 160 cells/dL, 95% CI 115-204, p =.0001, Wilcoxon signed rank test) after 48 weeks of treatment. Of 20 patients whose baseline viral load was <100000, 16 had viral load suppressed at 24 weeks and 15 at 48 weeks (p =.6, chi-square test). CONCLUSION: A regime of nevirapine with two nucleoside analogues provided durable suppression of plasma viral load in HIV infected patients, with significant improvement in the CD4 cell count.
Subject(s)
HIV Infections/drug therapy , Nevirapine/therapeutic use , Nucleosides/therapeutic use , Reverse Transcriptase Inhibitors/therapeutic use , Adult , CD4 Lymphocyte Count , Drug Therapy, Combination , Female , HIV Infections/immunology , HIV Infections/virology , HIV-1/drug effects , Humans , Male , Nevirapine/administration & dosage , Nevirapine/pharmacology , Nucleosides/administration & dosage , Nucleosides/pharmacology , Retrospective Studies , Reverse Transcriptase Inhibitors/administration & dosage , Reverse Transcriptase Inhibitors/pharmacology , Time Factors , Viral LoadSubject(s)
Testicular Neoplasms/diagnosis , Adult , Ambulatory Care , Humans , Lymphatic Metastasis , Male , Pain/etiologyABSTRACT
We carried out a two-phased study comparing the effectiveness of first-catch early morning urine (FCU) samples against urethral swabs for the detection of C. trachomatis in men. Four hundred and seventeen new and re-booked consecutive men, who attended the Department of Genito-Urinary Medicine, Bristol, having held their urine overnight, were recruited. Patients who had received antimicrobial chemotherapy in the preceding 2 months were excluded. Early morning FCU samples were obtained from 208 men followed by urethral swabs for the detection of C. trachomatis (phase I) and this order of collection was reversed for the remaining 209 patients (phase 2). A last-catch urine (LCU) was also obtained from all patients. All urethral and urine samples were examined by an amplified enzyme immunoassay (IDEIA, Dako Diagnostics Ltd). Initially, discordant samples were critically examined by direct immunofluorescence (Syva, 'Microtrak') which was used as the 'gold' standard in this study. We have shown that overall 42 and 4.7% of our symptomatic and asymptomatic male patients respectively were positive for C. trachomatis antigen by IDEIA. Furthermore 86.4 and 91.0% (phases 1 and 2) of the total C. trachomatis positive samples were detected by examination of an FCU sample. In contrast only 66.0 and 65.5% (phases 1 and 2) of the total positives were identified by examination of an urethral swab. These results show that an FCU sample not only has the advantage of being a non-invasive procedure but is also a very sensitive method, compared to swabbing the urethra for the detection of C. trachomatis.(ABSTRACT TRUNCATED AT 250 WORDS)
Subject(s)
Chlamydia Infections/diagnosis , Chlamydia trachomatis , Urethral Diseases/diagnosis , Antigens, Bacterial/analysis , Chlamydia Infections/urine , Chlamydia trachomatis/immunology , Chlamydia trachomatis/isolation & purification , Circadian Rhythm , Fluorescent Antibody Technique , Humans , Male , Specimen Handling , Time Factors , Urethra/microbiology , Urethral Diseases/microbiology , Urine/microbiologySubject(s)
Ofloxacin/therapeutic use , Oxytetracycline/therapeutic use , Urethritis/drug therapy , Humans , MaleABSTRACT
One hundred male sexual partners of women with anaerobic vaginosis (AV) were screened for the presence of sexually transmitted diseases (STD). Thirty male partners had evidence of non-gonococcal urethritis (NGU), compared to 5 in the control group (P less than 0.05). Chlamydia trachomatis was isolated from 14 male partners, compared to 3 in the control group. Forty-five male partners required treatment for STDs, compared to 11 in the control group (P less than 0.02). Nine (40%) male partners with chlamydia-negative NGU were successfully treated with metronidazole alone while 10 required Deteclo in addition. There was no significant association between Bacteroides ureolyticus and chlamydia-negative NGU. Screening of male partners resulted in the treatment of STDs in 62 additional patients who would have otherwise not received treatment. The results suggest that examination of male partners of women with AV results in an increased yield of STD diagnoses.
Subject(s)
Bacteria, Anaerobic , Bacterial Infections/etiology , Mass Screening/methods , Sexual Partners , Sexually Transmitted Diseases/epidemiology , Vaginal Diseases/etiology , Bacterial Infections/epidemiology , Bacterial Infections/microbiology , England/epidemiology , Female , Humans , Incidence , Male , Prevalence , Sexually Transmitted Diseases/microbiology , Sexually Transmitted Diseases/prevention & control , Vaginal Diseases/epidemiology , Vaginal Diseases/microbiologyABSTRACT
Clearview Chlamydia (Unipath Limited, Bedford, United Kingdom) is a rapid immunoassay for the direct detection of Chlamydia trachomatis antigen. This assay was evaluated against the tissue culture method by using 376 paired endocervical specimens. The Clearview assay had a sensitivity of 93.5% and a specificity of 99% when it was compared with the tissue culture method. This assay does not require specialized equipment or trained personnel and yields results within 30 min from the time that a specimen is collected.
Subject(s)
Chlamydia trachomatis/isolation & purification , Immunoassay/methods , Bacteriological Techniques , Chlamydia Infections/diagnosis , Diagnostic Errors , Evaluation Studies as Topic , Female , Humans , Sensitivity and Specificity , Uterine Cervicitis/diagnosisSubject(s)
Biopsy , Penile Diseases/diagnosis , Female , Humans , Male , Outpatient Clinics, Hospital , Penile Diseases/pathologyABSTRACT
Fifty patients presenting with either primary or recurrent patchy balanoposthitis which became aceto-white after the application of 5% acetic acid underwent biopsy. Microbiological screening, including Grocott staining of the biopsy material for fungal hyphae was performed. Forty nine biopsies showed marked koilocytosis suggestive of human papilloma virus (HPV) infection, and of these, only three showed fungal hyphae. This study suggests that HPV may be associated with some cases of patchy balanoposthitis.